1045 related articles for article (PubMed ID: 25896134)
1. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of periprosthetic femur fractures associated with a unique cementless stem design.
Watts CD; Abdel MP; Lewallen DG; Berry DJ; Hanssen AD
Clin Orthop Relat Res; 2015 Jun; 473(6):2045-53. PubMed ID: 25502478
[TBL] [Abstract][Full Text] [Related]
3. Exchangeable Femoral Neck (Dual-Modular) THA Prostheses Have Poorer Survivorship Than Other Designs: A Nationwide Cohort of 324,108 Patients.
Colas S; Allalou A; Poichotte A; Piriou P; Dray-Spira R; Zureik M
Clin Orthop Relat Res; 2017 Aug; 475(8):2046-2059. PubMed ID: 28194710
[TBL] [Abstract][Full Text] [Related]
4. Do Rerevision Rates Differ After First-time Revision of Primary THA With a Cemented and Cementless Femoral Component?
Gromov K; Pedersen AB; Overgaard S; Gebuhr P; Malchau H; Troelsen A
Clin Orthop Relat Res; 2015 Nov; 473(11):3391-8. PubMed ID: 25762017
[TBL] [Abstract][Full Text] [Related]
5. Conversion of Hemiarthroplasty to THA Carries an Increased Risk of Reoperation Compared With Primary and Revision THA.
Hernandez NM; Fruth KM; Larson DR; Kremers HM; Sierra RJ
Clin Orthop Relat Res; 2019 Jun; 477(6):1392-1399. PubMed ID: 31136440
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-osteoporosis medications on total hip arthroplasty risks in osteoporotic patients with hip osteoarthritis in Taiwan: a nationwide cohort study.
Hung CC; Wang CY; Fu SH; Yang RS; Hsiao FY
Arch Osteoporos; 2018 Oct; 13(1):107. PubMed ID: 30306268
[TBL] [Abstract][Full Text] [Related]
7. Patient and implant survival following intraoperative periprosthetic femoral fractures during primary total hip arthroplasty: an analysis from the national joint registry for England, Wales, Northern Ireland and the Isle of Man.
Lamb JN; Matharu GS; Redmond A; Judge A; West RM; Pandit HG
Bone Joint J; 2019 Oct; 101-B(10):1199-1208. PubMed ID: 31564148
[TBL] [Abstract][Full Text] [Related]
8. Long-term Mortality After Revision THA.
Yao JJ; Maradit Kremers H; Abdel MP; Larson DR; Ransom JE; Berry DJ; Lewallen DG
Clin Orthop Relat Res; 2018 Feb; 476(2):420-426. PubMed ID: 29389795
[TBL] [Abstract][Full Text] [Related]
9. Seasonality of Periprosthetic Femur Fractures in 12,700 Primary and Revision Total Hip Arthroplasties.
Trousdale WH; Abdel MP; Viste A; Trousdale RT; Callaghan JJ; Berry DJ
J Arthroplasty; 2017 Jun; 32(6):2000-2004. PubMed ID: 28341277
[TBL] [Abstract][Full Text] [Related]
10. Lower Total Knee Arthroplasty Revision Risk Associated With Bisphosphonate Use, Even in Patients With Normal Bone Density.
Namba RS; Inacio MC; Cheetham TC; Dell RM; Paxton EW; Khatod MX
J Arthroplasty; 2016 Feb; 31(2):537-41. PubMed ID: 26454569
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Preoperative Bisphosphonate Use on Total Hip Arthroplasty Outcomes.
Jeong S; Lee JW; Boucher HR
J Arthroplasty; 2023 Nov; 38(11):2393-2397.e2. PubMed ID: 37236285
[TBL] [Abstract][Full Text] [Related]
12. Periprosthetic Joint Infection in Hip Arthroplasty: Is There an Association Between Infection and Bearing Surface Type?
Pitto RP; Sedel L
Clin Orthop Relat Res; 2016 Oct; 474(10):2213-8. PubMed ID: 27249955
[TBL] [Abstract][Full Text] [Related]
13. What Is the Outcome of the First Revision Procedure of Primary THA for Osteoarthritis? A Study From the Australian Orthopaedic Association National Joint Replacement Registry.
de Steiger RN; Lewis PL; Harris I; Lorimer MF; Graves SE
Clin Orthop Relat Res; 2022 Oct; 480(10):1952-1970. PubMed ID: 35980886
[TBL] [Abstract][Full Text] [Related]
14. Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.
Bozic KJ; Kamath AF; Ong K; Lau E; Kurtz S; Chan V; Vail TP; Rubash H; Berry DJ
Clin Orthop Relat Res; 2015 Jun; 473(6):2131-8. PubMed ID: 25467789
[TBL] [Abstract][Full Text] [Related]
15. No Increase in Survival for 36-mm versus 32-mm Femoral Heads in Metal-on-polyethylene THA: A Registry Study.
Tsikandylakis G; Kärrholm J; Hailer NP; Eskelinen A; Mäkelä KT; Hallan G; Furnes ON; Pedersen AB; Overgaard S; Mohaddes M
Clin Orthop Relat Res; 2018 Dec; 476(12):2367-2378. PubMed ID: 30260863
[TBL] [Abstract][Full Text] [Related]
16. Periprosthetic atypical femoral fractures exist and are associated with duration of bisphosphonate therapy.
MacKenzie SA; Ng RT; Snowden G; Powell-Bowns MFR; Duckworth AD; Scott CEH
Bone Joint J; 2019 Oct; 101-B(10):1285-1291. PubMed ID: 31564154
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate Use May be Associated With an Increased Risk of Periprosthetic Hip Fracture.
Serino J; Terhune EB; Harkin WE; Weintraub MT; Baim S; Della Valle CJ
J Arthroplasty; 2024 Feb; 39(2):448-451.e1. PubMed ID: 37586595
[TBL] [Abstract][Full Text] [Related]
18. The influence of cemented femoral stem choice on the incidence of revision for periprosthetic fracture after primary total hip arthroplasty: an analysis of national joint registry data.
Palan J; Smith MC; Gregg P; Mellon S; Kulkarni A; Tucker K; Blom AW; Murray DW; Pandit H
Bone Joint J; 2016 Oct; 98-B(10):1347-1354. PubMed ID: 27694588
[TBL] [Abstract][Full Text] [Related]
19. The Frank Stinchfield Award : Total Hip Arthroplasty for Femoral Neck Fracture Is Not a Typical DRG 470: A Propensity-matched Cohort Study.
Schairer WW; Lane JM; Halsey DA; Iorio R; Padgett DE; McLawhorn AS
Clin Orthop Relat Res; 2017 Feb; 475(2):353-360. PubMed ID: 27154530
[TBL] [Abstract][Full Text] [Related]
20. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study.
Thillemann TM; Pedersen AB; Mehnert F; Johnsen SP; Søballe K
Bone; 2010 Apr; 46(4):946-51. PubMed ID: 20102756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
